# Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function

> **NCT00419237** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** GW685698X

## Key facts

- **NCT ID:** NCT00419237
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-13
- **Primary completion:** 2005-04-15
- **Final completion:** 2005-04-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419237, "Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00419237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*